Monday , January 18 2021

Pfizer is “not sure” whether its vaccine will stop the transfer of Covid-19



Health

Short URL

https://cdnfr1.img.sputniknews.com/img/07e4/0b/12/1044789885_0:0:3303:1859_1200x675_80_0_0_cad8465d10f3bb59ade5586c12765c15.jpg

Sputnik France

https://cdnfr2.img.sputniknews.com/i/logo.png

https://fr.sputniknews.com/sante/202012041044874708-pfizer-nest-pas-certain-que-son-vaccin-stoppe-la-transmission-du-covid-19/

“It’s something to check”: according to Albert Gourl, chief executive of pharmaceutical giant Pfizer, the company still doesn’t know if those receiving the Covid-19 vaccine can still carry the virus.

When Britain became the first country to authorize the Pfizer vaccine, its CEO, Albert Bourla, gave an interview to NBC News, giving details of the vaccine.

“Although I have received this protection, am I still able to [le coronavirus, ndlr] to pass it on to other people? Asked NBC reporter Lester Holt.

“I believe this is something that needs to be addressed,” replied the CEO. “We’re not sure what we know yet.”

Critique of pharmaceutical nationalism

The UK is the first country in the world to authorize a Pfizer vaccine with 40 million doses. It will be available from “next week” on Wednesday, December 2, a spokesman for the British government said.

The British government later announced that Brexit had made Britain the first Western country to allow the vaccine. A statement that earned criticism of pharmaceutical nationalism.

95% efficiency

On November 18, American pharmaceutical giant Pfizer and its German partner BioNTech announced that their vaccine candidate for Covid-19 was 95% effective.

The dose of Pfizer vaccine will cost $ 19.50 (about $ 16), so the cost of vaccination per person will be about $ 40 (almost $ 33).




Source link